ArticleCritical care (London, England)2019

Clinical use of [TIMP-2]•[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panel.

Louis M Guzzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.